Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Matthijs L, Becker"'
Publikováno v:
Patient Safety in Surgery, Vol 17, Iss 1, Pp 1-10 (2023)
Abstract Background Compliance with perioperative anticoagulation guidelines is essential to minimize bleeding and thromboembolic risks in patients undergoing surgery. Compared to vitamin-K antagonists (VKAs), perioperative management of direct oral
Externí odkaz:
https://doaj.org/article/6ed74eeb490f417c909586b9c786400c
Autor:
Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Thijs J. Giezen
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Many patients with inflammatory bowel disease (IBD) have transitioned from an infliximab originator to a biosimilar. However, some patients retransition to the originator (i.e. stop biosimilar and reinitiate the originator). Whether this
Externí odkaz:
https://doaj.org/article/77aacd70d06b45e8b69c4b191557d5ba
Autor:
Renate C. A. E. van Uden, Marit A. Bakker, Stephan G. L. Joosten, Karina Meijer, Patricia M. L. A. van den Bemt, Matthijs L. Becker, Marcia Vervloet
Publikováno v:
Pharmacy, Vol 11, Iss 3, p 80 (2023)
For several indications or combinations of indications the use of more than one antithrombotic agent is required. The duration of combined antithrombotic therapy depends on indication and patient characteristics. This study investigated the use of an
Externí odkaz:
https://doaj.org/article/9da286f6cb0a460990239fc2e44de9c2
Autor:
Florine A. Berger, Heleen van der Sijs, Matthijs L. Becker, Teun van Gelder, Patricia M. L. A. van den Bemt
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background The exact risk of developing QTc-prolongation when using a combination of QTc-prolonging drugs is still unknown, making it difficult to interpret these QT drug-drug interactions (QT-DDIs). A tool to identify high-risk patients is
Externí odkaz:
https://doaj.org/article/510aaaa02493400f90fca56dde66c0eb
Autor:
Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens, Thijs J. Giezen
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract The aim of this study was to assess switching patterns and determinants for switching in patients initiating TNFα inhibitor (TNFα‐i) treatment. Patients were included who started TNFα‐i treatment between July 1, 2012 and December 31,
Externí odkaz:
https://doaj.org/article/2c96570847574c73a0f95842dfcf6377
Autor:
Karlijn J van Stralen, Joyce E van Tol, Saskia N de Wildt, Matthijs L Becker, Marlies A van Houten
Publikováno v:
Archives of Disease in Childhood, 108, 62-66
Archives of Disease in Childhood, 108(1):324127, 62-66. BMJ Publishing Group
Archives of Disease in Childhood, 108, 1, pp. 62-66
Archives of Disease in Childhood, 108(1):324127, 62-66. BMJ Publishing Group
Archives of Disease in Childhood, 108, 1, pp. 62-66
ObjectiveWhen infants suffer from nasal congestion, xylometazoline spray or drops can be effective to facilitate breathing and drinking. However, case reports on side effects have resulted in international warnings regarding use of xylometazoline in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d03037d2c50d4146f3d5ee2c18ad51c
http://hdl.handle.net/2066/291654
http://hdl.handle.net/2066/291654
Autor:
Ashwin R. Moerlie, Renate C. van Uden, Aukje K. Mantel, Patricia van den Bemt, Matthijs L. Becker
Publikováno v:
Pharmacy Practice, Vol 18, Iss 2, p 1803 (2020)
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limi
Externí odkaz:
https://doaj.org/article/543ac6747a23444188a3be14ba7b9248
Autor:
Tessa Jaspers, Hylke Jan Kingma, Karina Meijer, Marcel P. H. van den Broek, Patricia M. L. A. van den Bemt, Diego A M Odekerken, Renate C A E van Uden, A.M. Harmsze, Matthijs L. Becker, Ilse Houtenbos
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 77(12), 1919-1926. Springer Verlag
European Journal of Clinical Pharmacology, 77(12), 1919-1926. Springer Verlag
Purpose Treatment schedules for antithrombotic therapy are complex, and there is a risk of inappropriate prescribing or continuation of antithrombotic therapy beyond the intended period of time. The primary aim of this study was to determine the freq
Autor:
Ilse Houtenbos, Renate C A E van Uden, Matthijs L. Becker, Diego A M Odekerken, Patricia M. L. A. van den Bemt, Anita Griffioen-Keijzer
Publikováno v:
Postgraduate Medical Journal. 97:730-737
Guidelines for antithrombotic therapy are complex, especially if a patient has several indications that require antithrombotic therapy. In general, no patient should receive lifelong double or triple antithrombotic therapy. In this overview, we outli
Autor:
Ruud T.M. van der Hoeven, Thijs J. Giezen, Soufiane Lilih, Marieke Pereboom, Matthijs L. Becker, Fatih Baypinar, Hylke Jan Kingma
Publikováno v:
International Journal of Clinical Pharmacy. 43:137-143
Background In advanced clinical decision support systems, patient characteristics and laboratory values are included in the algorithms that generate alerts. These alerts have a higher specificity than basic medication surveillance alerts. The alerts